Kirin (OTCMKTS:KNBWY) Shares Gap Down – Here’s Why

Kirin Holdings Co. (OTCMKTS:KNBWY) shares gapped down before the market opened on Friday . The stock had previously closed at $18.32, but opened at $17.35. Kirin shares last traded at $17.35, with a volume of 167 shares traded.

Analyst Upgrades and Downgrades

Separately, Zacks Research cut shares of Kirin from a “hold” rating to a “strong sell” rating in a research report on Monday, August 31st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.

Kirin Trading Down 2.4%

The company has a quick ratio of 1.01, a current ratio of 1.48 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $14.72 billion, a P/E ratio of 11.57 and a beta of -0.01. The firm has a 50 day moving average of $18.59 and a 200-day moving average of $17.29.

Kirin (OTCMKTS:KNBWY) last posted its quarterly earnings data on Friday, August 7th. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.42 by $0.16. The firm had revenue of $4.08 billion for the quarter, compared to analyst estimates of $3.87 billion. Kirin had a return on equity of 12.22% and a net margin of 7.79%. On average, equities research analysts predict that Kirin Holdings Co. will post 1.34 earnings per share for the current fiscal year.

About Kirin

Kirin Holdings Company, Limited is a Japan-based company with businesses spanning alcoholic and nonalcoholic beverages, pharmaceuticals and health science. Its beverage operations include beer, wine, spirits, soft drinks, bottled water and other consumer products marketed under brands such as Kirin, Ichiban Shibori and Afternoon Tea.

The company’s pharmaceutical business is conducted primarily through Kyowa Kirin, which researches, develops and commercializes prescription medicines, including treatments in areas such as oncology, immunology and nephrology.